ARTICLE | Company News
Sanofi endocrine/metabolic news
September 16, 2013 7:00 AM UTC
The U.S. District Court for the District of Utah ruled in Schubert v. Genzyme Corp. that Sanofi's Genzyme unit was under no affirmative duty to supply Fabry's disease therapy Fabrazyme agalsidase be...